Kristina Palmer

Charcoal Stripped Fetal Bovine Serum: A Vital Component for Hormone-Sensitive Research

by

Charcoal Stripped Fetal Bovine Serum (CS-FBS) is an essential tool in cell culture studies requiring precise control over hormone levels. The serum is treated with activated charcoal to remove small molecules like steroids, hormones, and growth factors. This allows researchers to study hormone signaling, drug responses, and growth factor-dependent pathways in a controlled environment without interference from endogenous molecules. CS-FBS is widely used in hormone receptor studies, cancer research, and cell differentiation experiments.

What is Charcoal Stripped Fetal Bovine Serum?

Fetal Bovine Serum (FBS) is a crucial component of cell culture media, providing nutrients, hormones, and growth factors that promote cell growth and division. However, in studies focused on hormone-sensitive pathways, the hormones naturally present in FBS can interfere with experimental outcomes. Charcoal stripping removes these hormones while leaving behind larger proteins necessary for cell culture, enabling more controlled and reproducible experiments. Learn more about the properties of FBS and its stripping process at NIH.gov and NCBI.

How is Charcoal Stripped FBS Made?

The process of charcoal stripping involves treating the serum with activated charcoal, which adsorbs small molecules like:

  • Steroid hormones (e.g., estrogen, testosterone)
  • Thyroid hormones (e.g., thyroxine)
  • Growth factors

Activated charcoal selectively removes these molecules without affecting larger proteins or essential nutrients. This method provides researchers with a hormone-free medium for controlled experimentation. For more details on the stripping process, visit FDA.gov and CDC.gov.

Applications of Charcoal Stripped FBS

  1. Hormone Receptor Studies
    CS-FBS is indispensable in research involving hormone receptors, such as estrogen receptors (ER) and androgen receptors (AR). Researchers use it to eliminate endogenous hormones and then add back known concentrations to study hormone receptor activity. This is particularly useful in cancer research, especially for hormone-sensitive cancers like breast and prostate cancer. For detailed information on hormone receptor assays, visit NIH.gov and Stanford University.
  2. Steroid Hormone Signaling
    Steroid hormones, including estrogen and testosterone, are key regulators of cellular processes. Using CS-FBS enables researchers to study the specific effects of added hormones without interference from endogenous steroids. This application is critical in understanding the mechanisms of steroid hormone signaling pathways. Find more on this topic at Harvard University and NCBI.
  3. Cell Differentiation Studies
    In stem cell and tissue differentiation research, CS-FBS helps eliminate the influence of extraneous hormones and growth factors that could alter cell fate decisions. By controlling the environment, researchers can focus on the specific factors driving differentiation. Read more on cell differentiation techniques using CS-FBS at Johns Hopkins University and NIH.gov.
  4. Drug Testing and Pharmacological Research
    CS-FBS is used in pharmacology to study how cells respond to drugs without interference from serum-derived hormones or growth factors. This allows for clearer observations of the drug’s effects. For research into drug testing protocols, visit FDA.gov and University of California, Berkeley.
  5. Endocrinology and Metabolic Research
    Studies in endocrinology often require hormone-depleted media to analyze metabolic responses or hormone regulation. CS-FBS ensures that experimental outcomes are not influenced by extraneous hormones, providing more accurate results. More on endocrinology research using CS-FBS can be found at University of Michigan and CDC.gov.

Advantages of Using Charcoal Stripped FBS

  1. Controlled Experimental Conditions
    CS-FBS provides researchers with the ability to precisely control hormone concentrations in their experiments, which is critical in hormone signaling research. By removing endogenous molecules, CS-FBS eliminates variability that could interfere with experimental results. Learn more about controlling experimental variables in cell culture at NCBI.
  2. Reproducibility
    The elimination of endogenous hormones and growth factors allows for greater reproducibility of results. This is essential for experiments where precise control over external variables is critical. Research on reproducibility in cell culture studies can be found at NIH.gov and Stanford University.
  3. Flexibility for Hormone Addition
    CS-FBS provides a hormone-depleted environment, enabling researchers to add specific hormones or growth factors back into the media at known concentrations. This flexibility is vital for studying dose-response relationships or hormone receptor activation. Detailed protocols for hormone addition using CS-FBS can be accessed at Johns Hopkins University and NCBI.

Limitations of Charcoal Stripped FBS

  1. Growth Factor Reduction
    While CS-FBS removes unwanted hormones, it can also deplete necessary growth factors that promote cell growth. Some cell lines may require additional supplementation to maintain healthy growth. Researchers often add back growth factors such as epidermal growth factor (EGF) or fibroblast growth factor (FGF). Information on growth factor supplementation is available at Harvard University and NIH.gov.
  2. Batch-to-Batch Variability
    As with all serum products, CS-FBS may exhibit variability between batches, which can affect experimental consistency. It’s important to validate each new batch of CS-FBS with control experiments to ensure consistent results. More on minimizing variability in serum batches can be found at CDC.gov and FDA.gov.

Future Directions: Serum-Free and Defined Media

There is a growing interest in moving toward serum-free and chemically defined media to provide even more control over experimental conditions. While CS-FBS offers a hormone-free environment, defined media formulations provide complete control over every component in the culture system. These formulations eliminate the need for serum altogether and allow for highly reproducible and precise cell culture conditions. For information on serum-free media and advancements in defined culture systems, visit NIH.gov and NCBI.

Conclusion

Charcoal Stripped Fetal Bovine Serum (CS-FBS) is an essential tool for studies that require a hormone-free environment. It allows researchers to focus on specific pathways, such as hormone receptor signaling, drug responses, and cell differentiation, without the confounding influence of endogenous molecules. With its controlled and reproducible conditions, CS-FBS remains indispensable for cutting-edge research in endocrinology, cancer studies, and pharmacology. For further reading and detailed experimental protocols, visit trusted sources like NIH.gov, NCBI, and CDC.gov.

Bradford Reagent: An Essential Tool for Protein Quantification

by

Bradford Reagent The Bradford Reagent is one of the most commonly used assays for determining protein concentration. Developed by Marion M. Bradford in 1976, this reagent has become a fundamental tool in molecular biology, biochemistry, and proteomics due to its simplicity and speed. The reagent uses Coomassie Brilliant Blue dye, which binds to proteins, causing a color change from reddish-brown to blue, allowing for quantification through spectrophotometry. For a deeper understanding of the history of this reagent, visit National Institutes of Health (NIH).

Principle of the Bradford Assay The Bradford Assay works based on the absorbance shift of Coomassie dye when bound to protein molecules. When the dye binds to basic (arginine) and aromatic amino acids (tryptophan, tyrosine), its maximum absorbance shifts from 465 nm to 595 nm, which can be measured using a spectrophotometer. This method is highly sensitive to protein concentrations between 1-100 µg/mL. For a detailed explanation of this absorbance shift, check University of California, San Francisco (UCSF).

Advantages of the Bradford Reagent The Bradford Assay offers several key advantages:

  • Rapid Results: Protein concentration can be measured within minutes, making it ideal for routine laboratory work.
  • High Sensitivity: Detects small quantities of protein, even at low concentrations.
  • Fewer Interferences: It is less affected by common reagents like reducing agents compared to other assays like the Lowry method.
  • Simplicity: Only a single reagent is required, unlike other methods that require multiple reagents. For more information on the assay’s simplicity, see Johns Hopkins University.

Limitations of the Bradford Reagent Despite its many advantages, the Bradford Reagent has certain limitations. The assay’s response can vary based on the type of protein, making it less reliable when comparing proteins with different amino acid compositions. Additionally, high concentrations of detergents such as SDS or Triton X-100 can interfere with the assay. For more information on the limitations, refer to Massachusetts Institute of Technology (MIT).

Comparison with Other Protein Assays Compared to methods like the Lowry or Bicinchoninic Acid (BCA) Assay, the Bradford Assay is quicker but may not be as accurate for all types of proteins. For large-scale or high-accuracy requirements, alternative assays like the BCA might be more appropriate. For a comparative study of these methods, visit Purdue University.

Applications of Bradford Reagent The Bradford Assay is widely used in research labs for protein quantification during various experiments, such as enzyme kinetics, protein purification, and cell lysate analysis. It is particularly useful in estimating protein concentrations before gel electrophoresis or Western blotting. More about these applications can be found at University of California, Davis.

Protocol for Using the Bradford Assay

  1. Reagent Preparation: The Bradford reagent is prepared by dissolving Coomassie Brilliant Blue G-250 in phosphoric acid and ethanol. For detailed instructions on preparing the reagent, see Harvard University’s Department of Molecular Biology.
  2. Sample Preparation: Protein samples are prepared along with a set of standards, typically using bovine serum albumin (BSA).
  3. Reagent Addition: Bradford Reagent is added to both standards and unknown samples.
  4. Incubation: The samples are incubated at room temperature for 5-10 minutes to allow the dye to bind to the proteins.
  5. Spectrophotometric Measurement: Absorbance is measured at 595 nm using a spectrophotometer. The protein concentration is determined based on a standard curve generated from the known standards. For an in-depth explanation of the assay protocol, visit Stanford University’s School of Medicine.

Optimizing the Bradford Assay To achieve the best results, it is important to carefully calibrate the spectrophotometer and use freshly prepared reagents. Protein precipitation can sometimes be an issue, particularly at high concentrations, so diluting the sample before testing can improve accuracy. For tips on optimization and troubleshooting, refer to University of Wisconsin-Madison’s Department of Biochemistry.

Interference in the Bradford Assay Some common laboratory reagents can interfere with the Bradford Assay. For example, detergents like SDS and Triton X-100 may alter the binding of the Coomassie dye to proteins. Reducing agents such as DTT and β-mercaptoethanol, often used in protein extraction buffers, can also interfere with the assay. However, the Bradford Assay is less susceptible to interference from these agents than other protein quantification methods like the Lowry Assay. More on reagent compatibility can be found at University of Texas at Austin.

Bradford Reagent in Clinical and Diagnostic Applications While primarily used in research, the Bradford Reagent also finds applications in clinical diagnostics, where accurate protein quantification is necessary for determining enzyme levels, proteinuria, or other protein-related conditions. For more details on its clinical applications, visit National Center for Biotechnology Information (NCBI).

Bradford Assay in Proteomics In proteomics, accurate quantification of protein samples is essential for analyzing protein expression levels and post-translational modifications. The Bradford Assay is commonly used to quantify protein samples before mass spectrometry and Western blotting, where precise amounts of protein are required. More about its use in proteomics is available at Yale University’s Department of Molecular Biophysics and Biochemistry.

Future Developments in Bradford Reagent Applications Ongoing research seeks to improve the sensitivity and accuracy of the Bradford Assay for detecting low-abundance proteins or minimizing interference from detergents and other reagents. Advances in colorimetric assays, including the development of modified Coomassie dyes, could further enhance the utility of the Bradford Reagent in future scientific applications. The National Institutes of Health (NIH) is funding several projects aimed at refining protein quantification techniques, including the Bradford Assay.

Conclusion The Bradford Reagent remains an indispensable tool for protein quantification in laboratories worldwide. While it has its limitations, its ease of use, rapid results, and wide applicability make it a favored choice for many researchers. For more comprehensive studies and applications, refer to trusted resources like the FDA and CDC.

Cusabio Vaccinia virus Recombinant

by

Shortly after the World Health Assembly resolution recommending the cessation of smallpox vaccination, proposals were made to use recombinant vaccinia viruses for immunization against other infectious agents. 161, 162 The idea was to stably insert one or more genes from other pathogens into the vaccinia virus genome while maintaining the latter’s infectivity. Furthermore, the high capacity of the vaccinia virus recombinant for foreign DNA raised the possibility of polyvalent vaccines against multiple diseases.

In principle, recombinant vaccinia viruses would have many of the properties of live attenuated virus vaccines and would naturally present antigens to stimulate humoral immunity to native protein conformation as well as cell-mediated immunity. Such vaccines could also retain the familiar advantages of the smallpox vaccine: heat stability, low cost, ease of administration, and a scar as visible proof of vaccination. Although recombinant vaccinia viruses are still being investigated for human and veterinary vaccination, their great value for vaccine research has been widely recognized.

Purity: greater than 85% as determined by SDS-PAGE.

Destination names: CTSK

Uniprot No.: P18378

Research Area: Others

Alternative names: (K2 protein)

Species: Vaccinia Virus (Western Reserve strain) (VACV) (Vaccinia virus (WR strain))

Source: Baculovirus

Expression Region: 1-88aa

Mole Weight: 11.6 kDa

Protein Length: Total length

Tag Information: N-terminal 6xHis-tagged

Form: Liquid or Lyophilized Powder

Note: We will preferably ship the format we have in stock, however, if you have any special requirements for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Buffer

If the dosage form is liquid, the default storage buffer is Tris/PBS based buffer, 5%-50% glycerol. If the administration form is a lyophilized powder, the buffer before lyophilization is a Tris/PBS-based buffer, 6% trehalose, pH 8.0.

Reconstitution

We recommend that this vial be briefly centrifuged before opening to bring the contents to the bottom. Reconstitute protein in sterile deionized water at a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and an aliquot for long-term storage at -20°C/-80°C. Our final default glycerol concentration is 50%. Customers could use it for reference.

Storage Conditions

Store at -20°C/-80°C upon receipt, need to be aliquoted for multiple uses. Avoid repeated cycles of freezing and thawing.

Shelf life

Shelf life is related to many factors, storage condition, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.

Delivery time

The delivery time may differ depending on the way or location of purchase, consult your local distributors for the specific delivery time.

Notes: Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

Vaccinia virus as a tool for vaccine research

Recombinant vaccinia viruses provide a powerful means of dissecting the immune responses of humans and experimental animals to individual gene products of infectious agents. Only a few examples can be mentioned here. Therefore, recombinant vaccinia viruses were used to demonstrate that influenza virus HA and NP proteins induced subtype-specific and cross-reactive cytotoxic T-cell responses, respectively. Evidence for human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T cells in patients with acquired immunodeficiency syndrome (AIDS) was first obtained by using recombinant vaccinia viruses expressing envelope or internal proteins to prepare target cells.

Indeed, recombinant vaccinia viruses have become an important tool for cellular immunologists. Because proteins expressed in mammalian cells by recombinant vaccinia viruses are normally folded, processed, and transported, they can be used to induce or bind antibodies that recognize conformational epitopes. The wide host range of vaccinia viruses makes it possible to determine protective immune responses against infectious agents in a variety of experimental animals, from rodents to primates.

For example, the F glycoprotein is more important for inducing protection against respiratory syncytial virus, while the HN protein is better for parainfluenza virus type 3 and type 5. Protection elicited by the virus’s M2 protein syncytial is due to CD8+ T cells, while that induced by F and G proteins is due to antibodies. Similar results, with respect to HA and NP proteins, have been obtained in studies with the influenza virus. In some cases, vaccination has a priming effect followed by an anamnestic antibody response, as suggested for the protection of chimpanzees after inoculation with a recombinant vaccinia virus expressing hepatitis B surface antigen. A list of viruses for which protective immune responses have been elicited can be found in a review.

Cusabio Plasmodium falciparum Recombinant

by

Introduction:

The production of recombinant proteins is essential for the characterization and functional study of Plasmodium falciparum proteins. However, Plasmodium falciparum Recombinant proteins are among the most difficult to express, and when the expression is achieved, recombinant proteins generally misfold leading to inclusion body formation.

Objective:

Obtain and purify four recombinant proteins and use them as antigens to produce polyclonal antibodies. Production efficiency and solubility were evaluated as proteins were expressed in two Escherichia coli strains genetically modified to favour heterologous protein production (BL21-CodonPlus (DE3)-RIL and BL21-pG-KJE8).

Materials and methods:

The four recombinant proteins of P. falciparum correspond to the partial sequences of PfMyoA (Myosin A) and PfGAP50 (slip-associated protein 50) and the complete sequences of PfMTIP (a protein that interacts with the myosin tail). and PfGAP45 (slip-associated protein 45), were produced as glutathione S-transferase fusion proteins, purified and used to immunize mice.

  • Parasites

Parasite strains P. falciparum FCR3S1.2 and TM284S2 were cultured according to standard methods with 10% AB+ Rh+ serum added to the buffered medium (RPMI supplemented with Hepes, gentamicin and sodium bicarbonate). Genomic DNA from these parasites was purified using the EasyDNA purification kit (Invitrogen) according to the manufacturer’s protocol.

  • Recombinant plasmids

Plasmid constructs for expression of the recombinant proteins GST-DBL1α and GST-CIDR1α of FCR3S1.2var 1PfEMP1, GST-DBL1α and GST-DBL2β of TM284S2var 1PfEMP1 were generated as described previously [18, 19].

  • Codon optimization and gene resynthesis

The sequence of the DBL1α domain of FCR3S1.2var 1PfEMP1 was optimized for codon matching in E. coli. Genes were chemically resynthesized (GeneArt, Germany). Resynthesized DBL1α was amplified with oligonucleotide primers (BL-1 5′-ATG GCT ACT TCC GGA GGA, BL-1.1 5′-TTC GAT AAG CAG AAG AAG TAC) and cloned into pGEX4T-1 vector.

  • E. coli strain

The BL21-CodonPlus-RIL strain purchased from Stratagene (California, USA) was used for protein expression. This bacterial strain has been engineered to contain a high copy number of arginine U, leucine W, and isoleucine Y tRNA genes for optimal expression of heterologous proteins from organisms with A/T-rich genetic sequences.

  • Expression of PfEMP1 domains in BL21-CodonPlus-RIL bacteria

Competent BL21 cells were transformed with recombinant pGEX4T-1 plasmids containing FCR3S1.2 DBL1α, TM284S2 DBL1α or TM284S2 DBL2β as inserts. Transformed bacteria were selected on LB agar plates containing ampicillin (100 µg/ml). A single colony of transformed bacteria was inoculated into 30 ml of LB medium containing ampicillin (100 µg/ml) and chloramphenicol (50 µg/ml) for growth at 37°C overnight. Aliquots of the culture were inoculated into one litre of LB medium containing ampicillin (100 µg/ml).

The cultivation was carried out with a stirring speed of 225 rpm. The pH value and the optical density at A600 of the cultures were systematically controlled. Aliquots (50 ml) of each culture were taken sequentially after the OD A600 reached 0.5 and IPTG (isopropyl-b-D-thiogalactopyranoside) was added to a final concentration of 0.1 mM to induce expression. Expression was carried out for three hours at 37°C and the bacteria were subsequently harvested by centrifugation at 4000 rpm for 15 minutes. Recombinant proteins were purified on glutathione-sepharose (Amersham-Pharmacia, Sweden).

  • SDS-PAGE analysis of recombinant proteins

To analyze the recombinant proteins, aliquots of the soluble and insoluble fractions of the expressed proteins from each purification were mixed with an equal volume of SDS-PAGE loading buffer containing β-mercaptoethanol and boiled at 100 °C for 5 min. Denatured proteins were resolved on 10% acrylamide gels containing 1% SDS and visualized by Coomassie brilliant blue solution staining.

  • Binding to heparin and blood group A antigen

Recombinant DBL1α purified from FCR3S1.2 expressed with pGEX plasmids containing the wild-type DBL1 sequence or the codon-optimized sequence was further passed through a HiTrap-heparin column (Amersham-Pharmacia Biotech, Sweden). After washing with PBS tween-20 buffer, bound protein was released from the column with 2M NaCl and immediately dialyzed against cold PBS. Aliquots of the eluted proteins were subjected to SDS-PAGE. The binding of recombinant FCR3S1.2 DBL1α to blood group A antigen was studied using a solid phase assay system.

Results:

Protein expression was much more efficient in BL21-CodonPlus, the strain containing tRNAs that are rare in wild-type E. coli, compared to expression in BL21-pG-KJE8. Although BL21-pG-KJE8 overexpresses chaperones, this strain did not minimize inclusion body formation.

Conclusion:

The use of genetically modified E. coli strains was essential to achieve high levels of expression of the four P. falciparum proteins evaluated and improve the solubility of two of them. The approach used here allowed us to obtain and purify four P. falciparum proteins in sufficient quantity to produce polyclonal antibodies in mice and a good quantity of two pure and soluble recombinant proteins for future tests.

Keywords: Escherichia coli.; Plasmodium falciparum; recombinant proteins.

Cusabio Pongo abelii Recombinant

by

They are extremely intelligent and have shown evidence of tool use and culture, traits once believed to be uniquely human. Despite being one of our closest relatives, human activities are having a devastating impact on the Sumatran orangutan and its habitat. They are the slowest reproducing of all mammals, with mothers caring for their young for up to 7 years. With such a low reproductive rate, even a small decrease in numbers can lead to extinction.

There are only two species in its genus Pongo abelii Recombinant, the other being the Bornean orangutan. They show more tool use than their sister species from Borneo; compiling a ‘toolbox’ about their lives. Its main threats include the destruction of its lowland rainforest habitat for palm oil plantations and agriculture, logging, the creation of new roads, as well as the death of some by humans or the illegal pet trade. Concerted conservation efforts are needed to prevent this peaceful primate from becoming the first great ape to become extinct in the wild.

Purity: >85% (SDS-PAGE)

Destination Names: PIC

Uniprot No.: Q5RBP8

Alternative Names: PFCs; appropriatedine; P-factor complement

Species: Pongo abelii (Sumatran Orangutan) (Pongo pygmaeus abelii)

Expression Region: 28-469

Protein length: Total length of the mature protein

Label information

The following labels are available.

  • N-terminus His-tagged
  • Without tags
  • The type of label will be determined during the production process. If you have specified a tag type, let us know and we will develop the specified tag preferentially.

Form: Lyophilized powder

Buffer before lyophilization: Tris/PBS based buffer, 6% trehalose, pH 8.0

Reconstitution

We recommend that this vial be briefly centrifuged before opening to bring the contents to the bottom. Reconstitute protein in sterile deionized water at a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and an aliquot for long-term storage at -20℃/-80℃. Our final default glycerol concentration is 50%. Customers could use it for reference.

Storage Conditions

Store at -20°C/-80°C upon receipt, need to be aliquoted for multiple uses. Avoid repeated cycles of freezing and thawing.

Shelf life

Shelf life is related to many factors, storage condition, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of the liquid form is 6 months at -20°C/-80°C. The shelf life of the lyophilized form is 12 months at -20°C/-80°C.

Delivery time

The delivery time may differ depending on the way or location of purchase, consult your local distributors for the specific delivery time.

Note: All of our proteins are shipped with regular blue ice packs by default. If you request shipping with dry ice, please contact us in advance and additional fees will be charged.

Notes:

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.

How are they recognized?

Orangutans are commonly called “red apes” as they have long, soft orange hair. His skin is dark grey. There is a difference in height, which varies from 1.30 m to 1.80 m, but the big difference is in weight, which ranges from 30 to 90 kg. An adult male can be three times as heavy as an adult female.

Orangutans are the largest arboreal animals in the world. As they mainly live high up in the trees, they have developed long arms (up to 2.25m) to help them swing through the forest. Both their feet and hands are incredibly dexterous and they have opposable thumbs like we do, making it easy to pick and peel fruit.

Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study

by
Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study

The significance of treating the bilateral neck in lateralized small oral cavity squamous cell carcinoma (OCC) is unclear. We sought to outline the incidence and predictors of contralateral neck failure (CLF) in sufferers who underwent unilateral remedy. Collaborative high quality consortia can facilitate implementation of high quality measures arising from medical databases. Our statewide basic thoracic surgical procedure (GTS) collaborative investigated the influences of cigarette smoking standing on mortality and main morbidity following lobectomy for lung most cancers.

Society of Thoracic Surgeons General Thoracic Surgery Database information have been recognized from 14 establishments collaborating in a statewide thoracic surgical high quality collaborative between 2012 and 2017. We excluded sufferers with nonelective procedures, stage Zero tumors, American Society of Anesthesiologists class VI illness, and lacking medical traits. Outcomes evaluation included the mixed mortality and main postoperative morbidity charges and the affect of affected person traits, together with smoking standing, on composite rate and on postoperative problems.
The study cohort included 2267 affected person information for evaluation. Overall mixed mortality and main morbidity rate was 10.2% (n = 231). Postoperative 30-day mortality was 1.5%, and main morbidity 9.6%. Significant predictors of the mixed end result included male intercourse (P = .004), physique mass index (P < .001), Zubrod rating (P = .02), smoking pack-years (P = .03), and thoracotomy (P < .001). Higher American Society of Anesthesiologists illness class and superior tumor stage have been marginally related to worse mixed end result (P = .06). Smoking standing; that’s, present, previous (no smoking inside 30 days), or by no means smoked, was not related to worse mixed end result (P = .56) and had no vital affect on main problems.
Smoking standing was not related to worse outcomes; nonetheless, smoking dose (pack-years) was related to worse mixed mortality and main morbidity. A statewide high quality collaborative supplies constructive suggestions for collaborating establishments and surgeons, selling high quality enchancment in perioperative affected person care methods and improved outcomes.

We carried out a multi-institutional retrospective study of sufferers with pathologic T1-T2 (AJCC seventh version) OCC with clinically node negative contralateral neck who underwent unilateral remedy with main surgical resection ± adjuvant radiotherapy between 2005 and 2015. Incidence of CLF was estimated utilizing the cumulative incidence methodology. Clinicopathological components have been analyzed by univariate (UVA) and multivariate evaluation (MVA) for attainable affiliation with CLF. Kaplan-Meier evaluation was used to estimate total survival (OS).

Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study

The subsequent era of collaborative care: The design of a novel web-based stepped collaborative care intervention delivered by way of telemedicine for individuals identified with most cancers

The NIH consensus assertion on cancer-related signs concluded the most typical and debilitating have been despair, ache and fatigue (American Cancer Society, 2019; Qaseem et al., 2008; Meijer et al., 2013; Meijer, 2011 [1-6]). Although the comorbidity of these signs is well-known and will have related underlying organic mechanisms; but no intervention has been developed to scale back these signs concurrently. The novel web-based stepped collaborative care intervention delivered by telemedicine is the first to be examined in individuals identified with most cancers.
We plan to check a web-based stepped collaborative care intervention with 450 most cancers sufferers and 200 caregivers in the context of a randomized managed trial. The main outcomes embrace the evaluation of patient-reported despair, ache, fatigue and high quality of life. Secondary end result embrace affected person serum ranges of pro-inflammatory cytokines and illness development. We additionally will assess casual caregiver stress, despair, and metabolic syndrome to find out if enhancements in sufferers’ signs additionally outcome in enchancment in caregiver outcomes.
The trial is ongoing and a complete of 370 affected person have been randomized. Preliminary analyses of the screening instruments used for study entry recommend that Center for Epidemiological Studies-Depression (CESD) scale has good sensitivity and specificity (0.77 and 0.85) whereas the scale used to evaluate ache (0.47 and 0.91) and fatigue (0.11 and 0.91) had poor sensitivity however glorious specificity. Using the AUROC, the finest minimize level for the CES-D was 15.5, for ache was 4.5; and for fatigue was 2.5. Outcomes not initially proposed included well being care utilization and healthcare fees. For the first 100 sufferers who’ve been adopted a yr post-treatment, and who have been lower than 75 years and randomized to the web-based stepped collaborative care intervention, had decrease charges of problems after surgical procedure [χ2 = 5.45, p = 0.02].
For sufferers who survived 6 months or much less and have been randomized to the web-based stepped collaborative care intervention, had decrease charges of 90-day readmissions when in comparison with sufferers randomized to the screening and referral arm [χ2 = 4.0, p = 0.046]. Patients randomized to the collaborative care intervention arm had decrease imply total well being care fees of $19,546 per affected person per yr when in comparison with the screening and referral arm.

Mouse Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE61503-96T 96T
EUR 561.6

Mouse Aβ1-42(Amyloid Beta 1-42) ELISA Kit
SYP-M0357-48wellsplate 48 wells plate
EUR 180

Mouse Aβ1-42(Amyloid Beta 1-42) ELISA Kit
SYP-M0357-96wellsplate 96 wells plate
EUR 220

Mouse Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925M-48wellsplate 48-wells plate
EUR 126

Mouse Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925M-96wellsplate 96-wells plate
EUR 180

Mouse Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
SEKM-0340
  • Ask for price
  • Ask for price
  • 48 Tests
  • 96 Tests

Mouse Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-M3010-24Tests 24 Tests
EUR 150
Description: Sandwich

Mouse Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-M3010-48Tests 48 Tests
EUR 396
Description: Sandwich

Mouse Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-M3010-96Tests 96 Tests
EUR 495
Description: Sandwich

Mouse Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-M3010-96Tests10 96 Tests *10
EUR 4950
Description: Sandwich

Mouse Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-M3010-96Tests5 96 Tests *5
EUR 2475
Description: Sandwich

MELISA-TEK® Meat Species Pork Kit
510321 96 Well Ask for price

MELISA-TEK® Meat Species Ruminant Kit
510311 96 Well Ask for price

MELISA-TEK® High Sensitivity Extraction Kit
510391 96 Well Ask for price

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E10787m-48T 48T
EUR 407.06
Description: Mus musculus (Mouse)

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E10787m-96T 96T
EUR 626.25
Description: Mus musculus (Mouse)

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0168Mo-1096T 10*96T
EUR 4122

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0168Mo-48wells 48 wells
EUR 300

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0168Mo-596T 5*96T
EUR 2061

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0168Mo-96wells 96 wells
EUR 458

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0181MS-48T 48T
EUR 403.2

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0181MS-48Tests 48 Tests Ask for price

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0181MS-96T 96T
EUR 640.8

Mouse amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0181MS-96Tests 96 Tests
EUR 460

EasyPro Mouse Amyloid Beta 1-42(Aβ1-42)ELISA Kit
FY-EM2925S each
EUR 520
Description: 1.88 pg/mL

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK0168Mo 96 wells Ask for price
Description: Mouse

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC40765-48T 48T
EUR 631.26

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC40765-5x96T 5x96T
EUR 4283.55

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC40765-96T 96T
EUR 901.8

Mouse amyloid beta peptide 1-42,Aβ1-42 Elisa Kit
EK732127 96 Wells
EUR 0.85

Mouse Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073m each
EUR 480

Mouse Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
NSL1640m 96 Test
EUR 528
Description: Sandwich ELISA

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0695MO-48T 48T Ask for price

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0695MO-96T 96T Ask for price

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CN-02503M1 96T
EUR 548.4

Mouse amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CN-02503M2 48T
EUR 367.2

Meat Speciation : EZ Pangasius™
510EZP 10 Tests Ask for price

Meat Speciation : EZ Pork™
530EZPK-10 10 Tests Ask for price

Meat Speciation : EZ Pork™ Raw
540EZPKR 10 Tests Ask for price

Rat Aβ1-42 ELISA Kit
ERA0919 96Tests
EUR 625.2

Goat Aβ1-42 ELISA Kit
EGTA0919 96Tests
EUR 625.2

Bovine Aβ1-42 ELISA Kit
EBA0919 96Tests
EUR 625.2

Canine Aβ1-42 ELISA Kit
ECA0919 96Tests
EUR 625.2

Rabbit Aβ1-42 ELISA Kit
ERTA0919 96Tests
EUR 625.2

Porcine Aβ1-42 ELISA Kit
EPA0919 96Tests
EUR 625.2

Anserini Aβ1-42 ELISA Kit
EAA0919 96Tests
EUR 625.2

Mouse amyloid beta peptide 1-42, Aβ1-42 GENLISA ELISA
KLM0168 1 x 96 wells
EUR 341

Mouse amyloid beta peptide 1-42-Aβ1-42-ELISA Kit
QY-E20081 96T
EUR 400

MF-Mouse Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925MF-48wellsplate 48-wells plate
EUR 140

MF-Mouse Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925MF-96wellsplate 96-wells plate
EUR 200

Guinea Pig Aβ1-42 ELISA Kit
EGA0919 96Tests
EUR 625.2

Mouse Aβ1-40 ELISA Kit
EMA0917 96Tests
EUR 625.2

Rat Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE62354-5x96T 5x96T
EUR 2667.6

Rat Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE62354-96T 96T
EUR 561.6

Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
SYP-R0291-48wellsplate 48 wells plate
EUR 180

Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
SYP-R0291-96wellsplate 96 wells plate
EUR 220

Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925R-48wells 48 wells
EUR 125.55

Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925R-48wellsplate 48-wells plate
EUR 126

Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925R-96wells 96 wells
EUR 179.55

Rat Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925R-96wellsplate 96-wells plate
EUR 180

Rat Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-R1402-24Tests 24 Tests
EUR 150
Description: Sandwich

Rat Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-R1402-48Tests 48 Tests
EUR 396
Description: Sandwich

Rat Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-R1402-96Tests 96 Tests
EUR 495
Description: Sandwich

Rat Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-R1402-96Tests10 96 Tests *10
EUR 4950
Description: Sandwich

Rat Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-R1402-96Tests5 96 Tests *5
EUR 2475
Description: Sandwich

Human Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE60376-5x96T 5x96T
EUR 2667.6

Human Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE60376-96T 96T
EUR 561.6

Human Aβ1-42(Amyloid Beta 1-42) ELISA Kit
SYP-H0170-48wellsplate 48 wells plate
EUR 180

Human Aβ1-42(Amyloid Beta 1-42) ELISA Kit
SYP-H0170-96wellsplate 96 wells plate
EUR 220

Human Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925H-48wells 48 wells
EUR 125.55

Human Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925H-48wellsplate 48 wells plate
EUR 126

Human Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925H-96wells 96 wells
EUR 179.55

Human Aβ1-42(Amyloid Beta 1-42) ELISA Kit
RE2925H-96wellsplate 96 wells plate
EUR 180

Monkey Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE61968-5x96T 5x96T
EUR 3503.6

Monkey Aβ1-42 (Amyloid Beta 1-42) ELISA Kit
EKE61968-96T 96T
EUR 737.6

Human Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-H0543-24Tests 24 Tests
EUR 150
Description: Sandwich

Human Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-H0543-48Tests 48 Tests
EUR 396
Description: Sandwich

Human Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-H0543-96Tests 96 Tests
EUR 495
Description: Sandwich

Human Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-H0543-96Tests10 96 Tests *10
EUR 4950
Description: Sandwich

Human Aβ1-42-Amyloid Beta 1-42- ELISA Kit
E-EL-H0543-96Tests5 96 Tests *5
EUR 2475
Description: Sandwich

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E10786r-48T 48T
EUR 417.3
Description: Rattus norvegicus (Rat)

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E10786r-96T 96T
EUR 642
Description: Rattus norvegicus (Rat)

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093Ra-1096T 10*96T
EUR 4122

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093Ra-48wells 48 wells
EUR 300

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093Ra-596T 5*96T
EUR 2061

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093Ra-96wells 96 wells
EUR 458

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0102RT-48T 48T
EUR 403.2

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0102RT-48Tests 48 Tests Ask for price

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0102RT-96T 96T
EUR 640.8

Rat amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
GA-E0102RT-96Tests 96 Tests
EUR 460

EasyPro Rat Amyloid Beta 1-42(Aβ1-42)ELISA Kit
FY-ER2925S each
EUR 520
Description: 9.38 pg/mL

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK0093Ra 96 wells Ask for price
Description: Rat

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC38655-48T 48T
EUR 647.15

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC38655-5x96T 5x96T
EUR 4391.38

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC38655-96T 96T
EUR 924.5

Rat amyloid beta peptide 1-42 (Aβ1-42) Elisa Kit
EK720347 96 Wells
EUR 0.56

Rat Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073r each
EUR 480

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0372RA-48T 48T Ask for price

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0372RA-96T 96T Ask for price

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CN-01630R1 96T
EUR 548.4

Rat amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CN-01630R2 48T
EUR 367.2

Goat Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073Go each
EUR 520

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E10684h-48T 48T
EUR 385.13
Description: Homo sapiens (Human)

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E10684h-96T 96T
EUR 592.5
Description: Homo sapiens (Human)

Human Amyloid beta peptide 1-42 (Aβ1-42) ELISA Kit
AE54777HU-48T 48T
EUR 360
Description: Human (Homo sapiens)

Human Amyloid beta peptide 1-42 (Aβ1-42) ELISA Kit
AE54777HU-48Tests 48 Tests
EUR 360
Description: Human (Homo sapiens)

Human Amyloid beta peptide 1-42 (Aβ1-42) ELISA Kit
AE54777HU-96T 96T
EUR 680
Description: Human (Homo sapiens)

Human Amyloid beta peptide 1-42 (Aβ1-42) ELISA Kit
AE54777HU-96Tests 96 Tests
EUR 680
Description: Human (Homo sapiens)

EasyPro Human Amyloid Beta 1-42(Aβ1-42)ELISA Kit
FY-EH2925S each
EUR 520
Description: 9.38 pg/mL

Human amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E1264Hu-1096T 10*96T
EUR 4122

Human amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E1264Hu-48wells 48 wells
EUR 300

Human amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E1264Hu-596T 5*96T
EUR 2061

Human amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E1264Hu-96wells 96 wells
EUR 458

Human amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK1264Hu 96 wells Ask for price
Description: Human

Human Amyloid beta peptide 1-42 (Aβ1-42) ELISA Kit
EK11141 96Т
EUR 799

Human amyloid beta peptide 1-42(Aβ1-42) Elisa Kit
EK700172 96 Wells
EUR 0.16

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC32566-48T 48T
EUR 597.24

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC32566-5x96T 5x96T
EUR 4052.7

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC32566-96T 96T
EUR 853.2

Human Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073h each
EUR 430

Human Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
NSL2245Hu 96 wells
EUR 468
Description: Sandwich ELISA

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0070HU-48T 48T Ask for price

Human amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0070HU-96T 96T Ask for price

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093MK-1096T 10*96T
EUR 4482

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093MK-48wells 48 wells
EUR 360

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093MK-596T 5*96T
EUR 2241

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0093MK-96wells 96 wells
EUR 498

Canine Amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0159Ca-1096T 10*96T
EUR 4275

Canine Amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0159Ca-48wells 48 wells
EUR 350

Canine Amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0159Ca-596T 5*96T
EUR 2137

Canine Amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0159Ca-96wells 96 wells
EUR 475

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E14398Mk-48T 48T
EUR 385.13
Description: Monkey

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
CSB-E14398Mk-96T 96T
EUR 592.5
Description: Monkey

Canine Amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK0159Ca 96 wells Ask for price
Description: Canine

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK0093MK 96 wells Ask for price
Description: Monkey

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC36131-48T 48T
EUR 597.24

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC36131-5x96T 5x96T
EUR 4052.7

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
EKC36131-96T 96T
EUR 853.2

Monkey amyloid beta peptide 1-42,Aβ1-42 Elisa Kit
EK763082 96 Wells
EUR 0.96

Bovine Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073Bo each
EUR 520

Canine Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073Ca each
EUR 520

Rabbit Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
EIA05073Rb each
EUR 520

Bovine Amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
NSL1648Bo 96 T
EUR 528
Description: Sandwich ELISA

Canine Amyloid beta peptide 1-42(Aβ1-42) ELISA Kit
SL0090Ca - Ask for price

Canine Amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
YLA0029CA-48T 48T Ask for price

Canine Amyloid beta peptide 1-42(Aβ1-42)ELISA Kit
YLA0029CA-96T 96T Ask for price

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0041MK-48T 48T Ask for price

Monkey amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
YLA0041MK-96T 96T Ask for price

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0082Po-1096T 10*96T
EUR 4122

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0082Po-48wells 48 wells
EUR 300

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0082Po-596T 5*96T
EUR 2061

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0082Po-96wells 96 wells
EUR 458

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
GA-E0087PC-48T 48T
EUR 436.8

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
GA-E0087PC-48Tests 48 Tests Ask for price

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
GA-E0087PC-96T 96T
EUR 708

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA Kit
GA-E0087PC-96Tests 96 Tests
EUR 520

Chicken amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK0341Ch 96 wells Ask for price
Description: Chicken

Porcine amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
JOT-EK0082Po 96 wells Ask for price
Description: Porcine

Chicken amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0341Ch-1096T 10*96T
EUR 4482

Chicken amyloid beta peptide 1-42,Aβ1-42 ELISA KIT
E0341Ch-48wells 48 wells
EUR 360
In a separate analyses centered on the caregivers, we discovered that after adjusting for age, gender, and race; low ranges of caregiver high quality of life (HR = 1.067, 95% CI = 1.019-1.117, p = 0.006), excessive ranges of hostility (HR = 1.142, 95% CI = 1.030-1.267, p = 0.012), and alcohol use (HR = 4.193, 95% CI = 1.174-14.978, p = 0.027) have been vital predictors of metabolic syndrome. The NCI-MATCH is a nationwide grasp protocol trial, printed in the Journal of Clinical Oncology, in which numerous tumors are sequenced and sufferers assigned to remedy. The trial demonstrates the feasibility of figuring out uncommon and customary actionable genetic alterations and underscores the power of educational/neighborhood partnerships for bettering trial entry.

A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol

by
A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol
Virtual Learning Collaboratives (VLC), studying communities centered on a widespread objective, are used incessantly in healthcare settings to implement finest practices. Yet, there may be restricted analysis testing the effectiveness of this strategy in contrast to different implementation strategies. This study evaluates the effectiveness of a VLC in contrast to Technical Assistance (TA) amongst neighborhood oncology practices implementing ENABLE (Educate, Nurture, Advise, Before Life Ends), an evidence-based, early palliative care telehealth, psycho-educational intervention for patients with newly identified advanced cancer and their caregivers.
 Using Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) and Proctor’s Implementation Outcomes Frameworks, this two-arm hybrid type-III cluster-randomized controlled trial (RCT) will evaluate two implementation strategies, VLC versus TA, among the many 48 National Cancer Institute Community Oncology Research Program (NCORP) observe clusters that haven’t traditionally supplied palliative care to all patients with advanced cancer. Three cohorts of observe clusters shall be randomized to the study arms. Each observe cluster will recruit 15-27 patients and a household caregiver to take part in ENABLE.
The main study consequence is ENABLE uptake (affected person degree), i.e., the proportion of eligible patients who full the ENABLE program (obtain a palliative care evaluation and full the six ENABLE classes over 12 weeks). The secondary consequence is general program implementation (observe cluster degree), as measured by the General Organizational Index at baseline, 6, and 12 months. Exploratory goals assess affected person and caregiver temper and high quality of life outcomes at baseline, 12, and 24 weeks. Practice cluster randomization will search to maintain the proportion of rural practices, observe sizes, and minority patients seen inside every observe
This study will advance the sphere of implementation science by evaluating VLC effectiveness, a generally used however understudied, implementation technique. The study will advance the sphere of palliative care by constructing the capability and infrastructure to implement an early palliative care program in neighborhood oncology practices. The LARS rating is an internationally well-accepted questionnaire to assess low anterior resection syndrome, however at the moment there isn’t any formally validated Italian model.
The English model of the LARS rating was translated into Italian following the forward-and-back translation course of. A whole of 147 patients crammed out our model. Among them, 40 patients answered the questionnaire twice for the test-retest reliability part. The validity of the LARS rating was examined utilizing convergent and discriminant validity indicators by correlating the EORTC QLQ-C30 and QLQ-CR29 questionnaires. The LARS rating functionality to differentiate teams of patients with totally different demographic or medical options was additionally assessed.

Performance Characteristics of the Ultrasound Strategy throughout Incidence Screening within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

Randomised controlled trials of ovarian cancer (OC) screening haven’t but demonstrated an affect on illness mortality. Meanwhile, the screening information from medical trials represents a wealthy useful resource to perceive the efficiency of modalities used. We report right here on incidence screening within the ultrasound arm of UKCTOCS. 44,799 of the 50,639 girls who had been randomised to annual screening with transvaginal ultrasound attended annual incidence screening between 28 April 2002 and 31 December 2011. Transvaginal ultrasound was used each as the primary and the second line check. Participants had been adopted up by way of digital well being report linkage and postal questionnaires.

Out of 280,534 annual incidence screens, 960 girls underwent screen-positive surgical procedure. 113 had ovarian/tubal cancer (80 invasive epithelial). Of the screen-detected invasive epithelial cancers, 37.5% (95% CI: 26.9-49.0) had been Stage I/II. An extra 52 (50 invasive epithelial) had been identified inside one yr of their final display screen. Of the 50 interval epithelial cancers, 6.0% (95% CI: 1.3-16.5) had been Stage I/II. For detection of all ovarian/tubal cancers identified inside one yr of display screen, the sensitivity, specificity, and optimistic predictive values had been 68.5% (95% CI: 60.8-75.5), 99.7% (95% CI: 99.7-99.7), and 11.8% (95% CI: 9.8-14) respectively.

When the evaluation was restricted to invasive epithelial cancers, sensitivity, specificity and optimistic predictive values had been 61.5% (95% CI: 52.6-69.9); 99.7% (95% CI: 99.7-99.7) and 8.3% (95% CI: 6.7-10.3), with 12 surgical procedures per display screen optimistic. The low sensitivity coupled with the advanced stage of interval cancers means that ultrasound scanning as the primary line check may not be appropriate for inhabitants screening for ovarian cancer. Trial registration: ISRCTN22488978. Registered on 6 April 2000.

A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol

The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer

Well-annotated, high-quality biorepositories present a priceless platform to assist translational analysis. However, most biorepositories have poor illustration of minority teams, limiting the power to deal with well being disparities. Methods: We describe the institution of the Florida Pancreas Collaborative (FPC), the primary state-wide potential cohort study and biorepository designed to deal with the upper burden of pancreatic cancer (PaCa) in African Americans (AA) in contrast to Non-Hispanic Whites (NHW) and Hispanic/Latinx (H/L).

We present an overview of stakeholders; study eligibility and design; recruitment strategies; customary working procedures to accumulate, course of, retailer, and switch biospecimens, medical photographs, and information; our cloud-based information administration platform; and progress relating to recruitment and biobanking. Results: The FPC consists of multidisciplinary groups from fifteen Florida medical establishments.

USP45 Polyclonal Antibody
ABP56799-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of USP45 from Human, Mouse, Rat. This USP45 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human USP45 at AA range: 270-350

USP45 Polyclonal Antibody
ABP56799-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of USP45 from Human, Mouse, Rat. This USP45 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human USP45 at AA range: 270-350

USP45 Polyclonal Antibody
BT-AP09447-100ul 100ul Ask for price
Description: The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. A wide range of enzymes facilitate the proteolytic Ub pathway, including USPs (ubiquitin specific peptidases), which are cysteine proteases that are responsible for the release of ubiquitin from a ubiquitylated substrate and precursor fusion proteins. USP45 (Ubiquitin carboxyl-terminal hydrolase 45), also known as Deubiquitinating enzyme 45, is a 819 amino acid protein that is involved in ubiquitin-dependent protein catabolism. USP45 differs from other USPs in that it contains a UBP-type zinc finger, a domain which binds ubiquitin. Although USP45 is broadly expressed, the highest levels can be found in skeletal muscle, spleen and ovary. There are three isoforms of USP45 which are produced as a result of alternative splicing.

USP45 Polyclonal Antibody
BT-AP09447-20ul 20ul Ask for price
Description: The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. A wide range of enzymes facilitate the proteolytic Ub pathway, including USPs (ubiquitin specific peptidases), which are cysteine proteases that are responsible for the release of ubiquitin from a ubiquitylated substrate and precursor fusion proteins. USP45 (Ubiquitin carboxyl-terminal hydrolase 45), also known as Deubiquitinating enzyme 45, is a 819 amino acid protein that is involved in ubiquitin-dependent protein catabolism. USP45 differs from other USPs in that it contains a UBP-type zinc finger, a domain which binds ubiquitin. Although USP45 is broadly expressed, the highest levels can be found in skeletal muscle, spleen and ovary. There are three isoforms of USP45 which are produced as a result of alternative splicing.

USP45 Polyclonal Antibody
BT-AP09447-50ul 50ul Ask for price
Description: The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. A wide range of enzymes facilitate the proteolytic Ub pathway, including USPs (ubiquitin specific peptidases), which are cysteine proteases that are responsible for the release of ubiquitin from a ubiquitylated substrate and precursor fusion proteins. USP45 (Ubiquitin carboxyl-terminal hydrolase 45), also known as Deubiquitinating enzyme 45, is a 819 amino acid protein that is involved in ubiquitin-dependent protein catabolism. USP45 differs from other USPs in that it contains a UBP-type zinc finger, a domain which binds ubiquitin. Although USP45 is broadly expressed, the highest levels can be found in skeletal muscle, spleen and ovary. There are three isoforms of USP45 which are produced as a result of alternative splicing.

USP45 Polyclonal Antibody
JOT-AP09447-100ul 100ul
EUR 220
Description: Human;Mouse;Rat

USP45 Polyclonal Antibody
JOT-AP09447-50ul 50ul
EUR 144
Description: Human;Mouse;Rat

USP45 Polyclonal Antibody
E20-74842 100ug
EUR 225
Description: Available in various conjugation types.

USP45 Polyclonal Antibody
E44H06376 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP45 Polyclonal Antibody
MBS2542642-002mL 0.02mL
EUR 140

USP45 Polyclonal Antibody
MBS2542642-006mL 0.06mL
EUR 180

USP45 Polyclonal Antibody
MBS2542642-012mL 0.12mL
EUR 260

USP45 Polyclonal Antibody
MBS2542642-02mL 0.2mL
EUR 405

USP45 Polyclonal Antibody
MBS2542643-002mL 0.02mL
EUR 140

USP45 Polyclonal Antibody
MBS2542643-006mL 0.06mL
EUR 180

USP45 Polyclonal Antibody
MBS2542643-012mL 0.12mL
EUR 260

USP45 Polyclonal Antibody
MBS2542643-02mL 0.2mL
EUR 405

USP45 Polyclonal Antibody
MBS8525823-01mg 0.1mg
EUR 305

USP45 Polyclonal Antibody
MBS8525823-01mLAF405L 0.1mL(AF405L)
EUR 465

USP45 Polyclonal Antibody
MBS8525823-01mLAF405S 0.1mL(AF405S)
EUR 465

USP45 Polyclonal Antibody
MBS8525823-01mLAF610 0.1mL(AF610)
EUR 465

USP45 Polyclonal Antibody
MBS8525823-01mLAF635 0.1mL(AF635)
EUR 465

USP45 Polyclonal Antibody
UB-GEN-2774 100 ul
EUR 200

USP18 Rabbit Polyclonal Antibody
54276 100ul
EUR 439

USP46 Rabbit Polyclonal Antibody
54471 100ul
EUR 439

USP11 Rabbit Polyclonal Antibody
54648 100ul
EUR 439

USP10 Rabbit Polyclonal Antibody
55238 100ul
EUR 439

USP26 Rabbit Polyclonal Antibody
55396 100ul
EUR 439

USP19 Rabbit Polyclonal Antibody
55609 100ul
EUR 439

USP13 Rabbit Polyclonal Antibody
53139 100ul
EUR 439

USP30 Rabbit Polyclonal Antibody
53436 100ul
EUR 439

USP30 Rabbit Polyclonal Antibody
53451 100ul
EUR 439

USP36 Rabbit Polyclonal Antibody
53506 100ul
EUR 439

USP10 Rabbit Polyclonal Antibody
53587 100ul
EUR 439

USP47 Rabbit Polyclonal Antibody
54041 100ul
EUR 439

USP53 Rabbit Polyclonal Antibody
ES6661-100ul 100ul
EUR 124
Description: IHC, ELISA

USP53 Rabbit Polyclonal Antibody
ES6661-50ul 50ul
EUR 74
Description: IHC, ELISA

USP40 Rabbit Polyclonal Antibody
ES6717-100ul 100ul
EUR 124
Description: WB, IHC, ELISA

USP40 Rabbit Polyclonal Antibody
ES6717-50ul 50ul
EUR 74
Description: WB, IHC, ELISA

USP36 Rabbit Polyclonal Antibody
ES6925-100ul 100ul
EUR 124
Description: WB, IHC, ELISA

USP36 Rabbit Polyclonal Antibody
ES6925-50ul 50ul
EUR 74
Description: WB, IHC, ELISA

USP44 Rabbit Polyclonal Antibody
ES7728-100ul 100ul
EUR 124
Description: WB, ELISA

USP44 Rabbit Polyclonal Antibody
ES7728-50ul 50ul
EUR 74
Description: WB, ELISA

USP48 Rabbit Polyclonal Antibody
ES7738-100ul 100ul
EUR 124
Description: IHC, WB, ELISA

USP48 Rabbit Polyclonal Antibody
ES7738-50ul 50ul
EUR 74
Description: IHC, WB, ELISA

USP32 Rabbit Polyclonal Antibody
ES7773-100ul 100ul
EUR 124
Description: IHC, WB, ELISA

USP32 Rabbit Polyclonal Antibody
ES7773-50ul 50ul
EUR 74
Description: IHC, WB, ELISA

USP13 Rabbit Polyclonal Antibody
ES7916-100ul 100ul
EUR 124
Description: WB, IHC, ELISA

USP13 Rabbit Polyclonal Antibody
ES7916-50ul 50ul
EUR 74
Description: WB, IHC, ELISA

USP15 Rabbit Polyclonal Antibody
ES8146-100ul 100ul
EUR 124
Description: WB, ELISA

USP15 Rabbit Polyclonal Antibody
ES8146-50ul 50ul
EUR 74
Description: WB, ELISA

USP11 Rabbit Polyclonal Antibody
ES4401-100ul 100ul
EUR 124
Description: WB, ELISA

USP11 Rabbit Polyclonal Antibody
ES4401-50ul 50ul
EUR 74
Description: WB, ELISA

USP16 Rabbit Polyclonal Antibody
ES4515-100ul 100ul
EUR 124
Description: WB, ELISA

USP16 Rabbit Polyclonal Antibody
ES4515-50ul 50ul
EUR 74
Description: WB, ELISA

USP19 Rabbit Polyclonal Antibody
ES4564-100ul 100ul
EUR 124
Description: WB, IHC, ELISA

USP19 Rabbit Polyclonal Antibody
ES4564-50ul 50ul
EUR 74
Description: WB, IHC, ELISA

USP43 Rabbit Polyclonal Antibody
ES4716-100ul 100ul
EUR 124
Description: WB, ELISA

USP43 Rabbit Polyclonal Antibody
ES4716-50ul 50ul
EUR 74
Description: WB, ELISA

USP24 Rabbit Polyclonal Antibody
ES5332-100ul 100ul
EUR 124
Description: IHC, ELISA

USP24 Rabbit Polyclonal Antibody
ES5332-50ul 50ul
EUR 74
Description: IHC, ELISA

USP22 Rabbit Polyclonal Antibody
E10G32859 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP21 Rabbit Polyclonal Antibody
E10G34582 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP51 Rabbit Polyclonal Antibody
E10G35068 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP29 Rabbit Polyclonal Antibody
E10G35079 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP16 Rabbit Polyclonal Antibody
E10G13367 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP50 Rabbit Polyclonal Antibody
E10G13620 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP10 Rabbit Polyclonal Antibody
E10G22998 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP11 Rabbit Polyclonal Antibody
E10G22999 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP13 Rabbit Polyclonal Antibody
E10G23005 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP16 Rabbit Polyclonal Antibody
E10G30068 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP21 Rabbit Polyclonal Antibody
E10G30148 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP28 Rabbit Polyclonal Antibody
E10G05499 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP24 Rabbit Polyclonal Antibody
E10G06038 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP32 Rabbit Polyclonal Antibody
E10G06039 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP37 Rabbit Polyclonal Antibody
E10G06040 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP11 Rabbit Polyclonal Antibody
E10G06367 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP16 Rabbit Polyclonal Antibody
E10G06478 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP43 Rabbit Polyclonal Antibody
E10G06922 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP39 Rabbit Polyclonal Antibody
E10G08956 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP15 Rabbit Polyclonal Antibody
E10G08959 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP47 Rabbit Polyclonal Antibody
E10G08961 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP39 Rabbit Polyclonal Antibody
E10G01986 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP15 Rabbit Polyclonal Antibody
E10G01989 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP47 Rabbit Polyclonal Antibody
E10G01991 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP12 Rabbit Polyclonal Antibody
E10G02359 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP21 Rabbit Polyclonal Antibody
E10G02360 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP35 Rabbit Polyclonal Antibody
E10G02362 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP14 Rabbit Polyclonal Antibody
E10G02363 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP53 Rabbit Polyclonal Antibody
E10G02847 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP30 Rabbit Polyclonal Antibody
E10G03546 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP12 Rabbit Polyclonal Antibody
E10G09324 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP21 Rabbit Polyclonal Antibody
E10G09325 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP25 Rabbit Polyclonal Antibody
E10G09326 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP32 Rabbit Polyclonal Antibody
E10G09327 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP38 Rabbit Polyclonal Antibody
E10G09328 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP35 Rabbit Polyclonal Antibody
E10G09330 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP14 Rabbit Polyclonal Antibody
E10G09331 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP53 Rabbit Polyclonal Antibody
E10G09847 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP30 Rabbit Polyclonal Antibody
E10G10552 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP43 Rabbit Polyclonal Antibody
E10G31436 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP28 Rabbit Polyclonal Antibody
E10G12376 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP24 Rabbit Polyclonal Antibody
E10G12924 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP32 Rabbit Polyclonal Antibody
E10G12925 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP37 Rabbit Polyclonal Antibody
E10G12926 100 μl
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

USP30 Rabbit Polyclonal Antibody
ES3678-100ul 100ul
EUR 124
Description: WB, ELISA

USP30 Rabbit Polyclonal Antibody
ES3678-50ul 50ul
EUR 74
Description: WB, ELISA

USP38 Rabbit Polyclonal Antibody
ES3679-100ul 100ul
EUR 124
Description: WB, ELISA

USP38 Rabbit Polyclonal Antibody
ES3679-50ul 50ul
EUR 74
Description: WB, ELISA

USP42 Rabbit Polyclonal Antibody
ES3680-100ul 100ul
EUR 124
Description: WB, ELISA

USP42 Rabbit Polyclonal Antibody
ES3680-50ul 50ul
EUR 74
Description: WB, ELISA

USP50 Rabbit Polyclonal Antibody
ES3681-100ul 100ul
EUR 124
Description: WB, IHC, ELISA

USP50 Rabbit Polyclonal Antibody
ES3681-50ul 50ul
EUR 74
Description: WB, IHC, ELISA

USP30 Rabbit Polyclonal Antibody
MBS9467636-005mL 0.05mL
EUR 300

USP30 Rabbit Polyclonal Antibody
MBS9467636-01mL 0.1mL
EUR 390

USP30 Rabbit Polyclonal Antibody
MBS9467636-5x01mL 5x0.1mL
EUR 1610

USP11 Rabbit Polyclonal Antibody
MBS9467758-005mL 0.05mL
EUR 300

USP11 Rabbit Polyclonal Antibody
MBS9467758-01mL 0.1mL
EUR 390

USP11 Rabbit Polyclonal Antibody
MBS9467758-5x01mL 5x0.1mL
EUR 1610

USP15 Rabbit Polyclonal Antibody
MBS9466066-005mL 0.05mL
EUR 300

USP15 Rabbit Polyclonal Antibody
MBS9466066-01mL 0.1mL
EUR 390

USP15 Rabbit Polyclonal Antibody
MBS9466066-5x01mL 5x0.1mL
EUR 1610

USP10 Rabbit Polyclonal Antibody
MBS9466266-005mL 0.05mL
EUR 300

USP10 Rabbit Polyclonal Antibody
MBS9466266-01mL 0.1mL
EUR 390

USP10 Rabbit Polyclonal Antibody
MBS9466266-5x01mL 5x0.1mL
EUR 1610

USP26 Rabbit Polyclonal Antibody
MBS9466421-005mL 0.05mL
EUR 300

USP26 Rabbit Polyclonal Antibody
MBS9466421-01mL 0.1mL
EUR 390

USP26 Rabbit Polyclonal Antibody
MBS9466421-5x01mL 5x0.1mL
EUR 1610

USP19 Rabbit Polyclonal Antibody
MBS9466620-005mL 0.05mL
EUR 300

USP19 Rabbit Polyclonal Antibody
MBS9466620-01mL 0.1mL
EUR 390

USP19 Rabbit Polyclonal Antibody
MBS9466620-5x01mL 5x0.1mL
EUR 1610

USP13 Rabbit Polyclonal Antibody
MBS9464416-005mL 0.05mL
EUR 300

USP13 Rabbit Polyclonal Antibody
MBS9464416-01mL 0.1mL
EUR 390

USP13 Rabbit Polyclonal Antibody
MBS9464416-5x01mL 5x0.1mL
EUR 1610

USP30 Rabbit Polyclonal Antibody
MBS9464710-005mL 0.05mL
EUR 300

USP30 Rabbit Polyclonal Antibody
MBS9464710-01mL 0.1mL
EUR 390

USP30 Rabbit Polyclonal Antibody
MBS9464710-5x01mL 5x0.1mL
EUR 1610

USP36 Rabbit Polyclonal Antibody
MBS9464764-005mL 0.05mL
EUR 300

USP36 Rabbit Polyclonal Antibody
MBS9464764-01mL 0.1mL
EUR 390

USP36 Rabbit Polyclonal Antibody
MBS9464764-5x01mL 5x0.1mL
EUR 1610

USP10 Rabbit Polyclonal Antibody
MBS9464840-005mL 0.05mL
EUR 300

USP10 Rabbit Polyclonal Antibody
MBS9464840-01mL 0.1mL
EUR 390

USP10 Rabbit Polyclonal Antibody
MBS9464840-5x01mL 5x0.1mL
EUR 1610

USP47 Rabbit Polyclonal Antibody
MBS9465261-005mL 0.05mL
EUR 300

USP47 Rabbit Polyclonal Antibody
MBS9465261-01mL 0.1mL
EUR 390

USP47 Rabbit Polyclonal Antibody
MBS9465261-5x01mL 5x0.1mL
EUR 1610

USP18 Rabbit Polyclonal Antibody
MBS9465481-005mL 0.05mL
EUR 300

USP18 Rabbit Polyclonal Antibody
MBS9465481-01mL 0.1mL
EUR 390

USP18 Rabbit Polyclonal Antibody
MBS9465481-5x01mL 5x0.1mL
EUR 1610

USP46 Rabbit Polyclonal Antibody
MBS9465616-005mL 0.05mL
EUR 300

From March 2019 by way of August 2020, 350 patients had been assessed for eligibility, 323 met inclusion/exclusion standards, and 305 (94%) enrolled, together with 228 NHW, 30 AA, and 47 H/L, with 94%, 100%, and 94% participation charges, respectively. A excessive share of contributors have donated blood (87%), pancreatic tumor tissue (41%), computed tomography scans (76%), and questionnaires (62%).  This biorepository addresses a vital hole in PaCa analysis and has potential to advance translational research meant to decrease disparities and cut back PaCa-related morbidity and mortality.

Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and high-fat diet using the collaborative cross (CC) lines

by
Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and high-fat diet using the collaborative cross (CC) lines

Multimorbidity of intestinal cancer (IC), type 2 diabetes (T2D) and obesity is a posh set of ailments, affected by environmental and genetic threat components. High-fat diet (HFD) and oral bacterial infection play essential roles in the etiology of these ailments by way of irritation and numerous organic mechanisms.  To research the complexity of this multimorbidity, we used the collaborative cross (CC) mouse genetics reference inhabitants. We aimed to research the multimorbidity of IC, T2D, and obesity using CC lines, measuring their responses to HFD and oral bacterial infection.

The research used 63 mice of each sexes generated from two CC lines (IL557 and IL711). For 12 weeks, experimental mice have been maintained on particular dietary regimes mixed with co-infection with oral micro organism Porphyromonas gingivalis and Fusobacterium nucleatum, whereas management teams weren’t contaminated. Body weight (BW) and outcomes of a intraperitoneal glucose tolerance check (IPGTT) have been recorded at the finish of 12 weeks, after which size and dimension of the intestines have been assessed for polyp counts. Polyp counts ranged between 2 and 10 per CC line.

The mixture of HFD and infection considerably diminished (P < .01) the colon polyp dimension of IL557 females to 2.5 cm2, in contrast to the different teams. Comparing BW achieve, IL557 males on HFD gained 18 g, whereas the females gained 10 g below the similar situations and confirmed the highest space below curve (AUC) values of 40 000-45 000 (min mg/dL) in the IPGTT. The outcomes present that mice from completely different genetic backgrounds reply in another way to a excessive fats diet and oral infection in phrases of polyp improvement and glucose tolerance, and this impact is gender associated.

Data have been extracted from the standardized Quality Data Collection Tool (QDACT). Adults with pancreatic cancer seen by a palliative care supplier have been included. Descriptive statistics have been used to describe demographic options, symptom prevalence and burden, in addition to assess affected person prognosis consciousness outlined by congruence or incongruence with supplier estimated prognosis.

Effect of Collaborative Review of Electronic Patient-Reported Outcomes for Shared Reporting in Breast Cancer Patients: Descriptive Comparative Study

Digital monitoring of treatment-related signs and self-reported affected person outcomes is essential for the high quality of care amongst cancer sufferers. As cellular gadgets are ubiquitous these days, the assortment of digital patient-reported outcomes (ePROs) is gaining momentum. So far, information are missing on the modalities that contribute to the amount and high quality of ePROs.  The goal of our research was to examine the utilization of two variations of a subsequently employed cellular app for digital monitoring of PROs and to check our speculation {that a} shared evaluation of signs in patient-physician collaboration has an affect on the quantity of information entries.
 The Consilium Care app engages cancer sufferers to standardize reporting of well-being and treatment-related signs in outpatient settings. For descriptive comparability of the utilization of two barely completely different app variations, information have been obtained from an early breast cancer trial (model 1 of the app, n=86) and an ongoing research together with sufferers with superior illness (model 2 of the app, n=106). In each app variations, sufferers and docs have been allowed to share the info from information entries throughout consultations.  The numbers and varieties of symptom entries, satisfaction with each app variations, and sufferers’ perceived effects throughout consultations have been included for evaluation.
Symptom severity grading was carried out in accordance to the Common Terminology Criteria for Adverse Events (CTCAE) using a horizontal slider and was indicated in descriptive terminology in each apps, whereas a graphical show facilitated the illustration of symptom historical past charts. In whole, 192 sufferers electronically reported 11,437 information entries on well-being and 33,380 information entries on particular person signs. Overall, 628 (of 872 supposed) requested patient-doctor symptom critiques have been carried out in model 2 of the app.
Both the quantity of information entries per affected person and day for well-being (model 1 vs model 2: 0.three vs 1.0; P<.001) and signs (model 1 vs model 2: 1.three vs 1.9; P=.04) appeared considerably elevated in model 2 of the app. Overall satisfaction with each app variations was excessive, though model 2 of the app was perceived to be extra useful in basic. Version 2 of the app, nevertheless, randomly chosen signs that required an in depth and shared common patient-doctor evaluation in order to focus on the assortment and acceptable interpretation concerning consciousness and steerage for severity grading.
Studying host genetic background effects on multimorbidity of intestinal cancer development, type 2 diabetes and obesity in response to oral bacterial infection and high-fat diet using the collaborative cross (CC) lines

Dancing With Health: Quality of Life and Physical Improvements From an EU Collaborative Dance Programme With Women Following Breast Cancer Treatment

Women’s well being has obtained renewed consideration in the previous few years together with well being rehabilitation choices for girls affected by breast cancer. Dancing has usually been considered one enticing possibility for supporting girls’s well-being and well being, however analysis with girls recovering from breast cancer continues to be in its infancy. Dancing with Health is multi-site pilot research that aimed to consider a dance programme for girls in restoration from breast cancer throughout 5 European nations.

A standardized 32 h dance protocol launched a variety of Latin American dances offered inside a sports activities and train framework with influences from dance motion remedy. Fifty-four girls (M age 53.51; SD 7.99) participated in the research who had a breast cancer prognosis <three years, chemotherapy >6 weeks, no indication of metastasis, or scheduled surgical procedure/chemotherapy/radiation remedy for the length of the intervention. Primary consequence information was collected for anthropometric and health measures subsequent to cancer-related high quality of life. T-tests and Wilcoxon signed ranked checks have been used to set up variations pre and publish intervention.

MIPT3 Antibody
abx119584-50l 50 µl
EUR 237.5

MIPT3 Antibody
E11-13085C 100μg
EUR 225
Description: Available in various conjugation types.

MIPT3 antibody
MBS5300537-01mg 0.1mg
EUR 465

MIPT3 antibody
MBS5300537-5x01mg 5x0.1mg
EUR 1945

MIPT3 Antibody
MBS853423-01mg 0.1mg
EUR 305

MIPT3 Antibody
MBS853423-01mLAF405L 0.1mL(AF405L)
EUR 465

MIPT3 Antibody
MBS853423-01mLAF405S 0.1mL(AF405S)
EUR 465

MIPT3 Antibody
MBS853423-01mLAF610 0.1mL(AF610)
EUR 465

MIPT3 Antibody
MBS853423-01mLAF635 0.1mL(AF635)
EUR 465

MIPT3 Antibody
MBS9505833-005mL 0.05mL
EUR 285

MIPT3 Antibody
MBS9505833-01mL 0.1mL
EUR 385

MIPT3 Antibody
MBS9505833-5x01mL 5x0.1mL
EUR 1590

MIPT3 antibody
70R-33832 100 ug Ask for price

MIP-T3 Antibody
C13085-100ul 100μl
EUR 217
Description: MIP-T3 Rabbit Polyclonal Antibody

MIP-T3 Antibody
C13085-50ul 50μl
EUR 143.5
Description: MIP-T3 Rabbit Polyclonal Antibody

MIP-T3 Polyclonal Antibody
ABP54468-003ml 0.03ml
EUR 189.6
Description: A polyclonal antibody for detection of MIP-T3 from Human. This MIP-T3 antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MIP-T3 at AA rangle: 190-270

MIP-T3 Polyclonal Antibody
ABP54468-01ml 0.1ml
EUR 346.8
Description: A polyclonal antibody for detection of MIP-T3 from Human. This MIP-T3 antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MIP-T3 at AA rangle: 190-270

MIP-T3 Polyclonal Antibody
ABP54468-02ml 0.2ml
EUR 496.8
Description: A polyclonal antibody for detection of MIP-T3 from Human. This MIP-T3 antibody is for IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human MIP-T3 at AA rangle: 190-270

MIP-T3 Polyclonal Antibody
BT-AP05430-100ul 100ul Ask for price
Description: Play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules.

MIP-T3 Polyclonal Antibody
BT-AP05430-20ul 20ul Ask for price
Description: Play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules.

MIP-T3 Polyclonal Antibody
BT-AP05430-50ul 50ul Ask for price
Description: Play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules.

MIP-T3 Polyclonal Antibody
JOT-AP05430-100ul 100ul
EUR 220
Description: Human

MIP-T3 Polyclonal Antibody
JOT-AP05430-50ul 50ul
EUR 144
Description: Human

MIP-T3 Polyclonal Antibody
E44H05276 100ul
EUR 255
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

MIP-T3 Polyclonal Antibody
E20-72768 100ug
EUR 225
Description: Available in various conjugation types.

MIP-T3 Polyclonal Antibody
MBS8523749-01mg 0.1mg
EUR 305

MIP-T3 Polyclonal Antibody
MBS8523749-01mLAF405L 0.1mL(AF405L)
EUR 465

MIP-T3 Polyclonal Antibody
MBS8523749-01mLAF405S 0.1mL(AF405S)
EUR 465

MIP-T3 Polyclonal Antibody
MBS8523749-01mLAF610 0.1mL(AF610)
EUR 465

MIP-T3 Polyclonal Antibody
MBS8523749-01mLAF635 0.1mL(AF635)
EUR 465

MIP-T3 Polyclonal Antibody
UB-GEN-3875 100 ul
EUR 200

Rapid Human Antibody Isotyping Kit, 5pk
113101 5 PKS Ask for price

MIP-T3 Rabbit Polyclonal Antibody
ES5467-100ul 100ul
EUR 124
Description: IHC, IF, ELISA

MIP-T3 Rabbit Polyclonal Antibody
ES5467-50ul 50ul
EUR 74
Description: IHC, IF, ELISA

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3)
MBS643331-02mL 0.2mL
EUR 695

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3)
MBS643331-5x02mL 5x0.2mL
EUR 2975

Anti-MIPT3 TRAF3IP1 Antibody
A08944 100ul
EUR 335
Description: Boster Bio Anti-MIPT3 TRAF3IP1 Antibody (Catalog# A08944). Tested in WB, IHC-P, IF, ICC, ELISA applications. This antibody reacts with Human, Rat, Mouse.

Anti Human Alpha 1Anti Human Chymotrypsin Pab
111444 100 µg Ask for price

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (AP)
MBS6357857-02mL 0.2mL
EUR 980

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (AP)
MBS6357857-5x02mL 5x0.2mL
EUR 4250

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (PE)
MBS6357867-02mL 0.2mL
EUR 980

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (PE)
MBS6357867-5x02mL 5x0.2mL
EUR 4250

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (APC)
MBS6357858-02mL 0.2mL
EUR 980

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (APC)
MBS6357858-5x02mL 5x0.2mL
EUR 4250

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (Biotin)
MBS6357859-02mL 0.2mL
EUR 980

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (Biotin)
MBS6357859-5x02mL 5x0.2mL
EUR 4250

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (FITC)
MBS6357860-02mL 0.2mL
EUR 980

TRAF3IP1, ID (TRAF3IP1, MIPT3, TRAF3-interacting protein 1, Interleukin-13 receptor alpha 1-binding protein 1, Microtubule-interacting protein associated with TRAF3) (FITC)
MBS6357860-5x02mL 5x0.2mL
EUR 4250

Anti Human LH Pab
111053 100 µg Ask for price

Anti Human C3 Mab
111163 100 µg Ask for price

Anti Human C5 Mab
111164 100 µg Ask for price

Anti Human TF Pab
111263 100 µg Ask for price

Anti Human LYN Mab
831082 100 µg Ask for price

Anti Human FYN Mab
831084 100 µg Ask for price

Anti Human PSA Pab
165726 100 µg Ask for price

Anti Human CD2 Mab
272062 100 µg Ask for price

Anti Human C4a Mab
272103 100 µg Ask for price

Anti Human FSH Mab
272142 1 mg Ask for price

Anti Human FSH Pab
272143 100 µg Ask for price

Anti Human CPD Pab
272458 100 µg Ask for price

Anti Human IgE Mab
121026 100 µg Ask for price

Anti Human PAI Pab
164045 100 µg Ask for price

Anti Human Tau Mab
164070 100 µg Ask for price

Anti Human BNP Pab
165460 100 µg Ask for price

Anti Human C4d Pab
165468 100 µg Ask for price

Anti Human CD2 Pab
165486 100 µg Ask for price

Anti Human CD7 Pab
165491 100 µg Ask for price

Anti Human CEA Pab
165493 100 µg Ask for price

Anti Human CK7 Pab
165510 100 µg Ask for price

Anti Human EGF Pab
165555 100 µg Ask for price

Anti Human Tau Pab
111112 100 µg Ask for price

Anti Human p53 Pab
111304 100 µg Ask for price

Anti Human FLK Pab
111462 100 µg Ask for price

Anti Human C4b Pab
111488 100 µg Ask for price

Anti Human CD8 Pab
111494 100 µg Ask for price

Anti Human Mu2 Pab
111499 100 µg Ask for price

Anti Human ROS Pab
111519 100 µg Ask for price

Anti Human FGR Pab
111676 100 µg Ask for price

Anti Human JUN Pab
111686 100 µg Ask for price

Anti Human LYN Pab
111689 100 µg Ask for price

Anti Human MET Pab
111693 100 µg Ask for price

Anti Human MYC Pab
111694 100 µg Ask for price

Anti Human REL Pab
111712 100 µg Ask for price

Anti Human CA 15-3 Pab
165469 100 µg Ask for price

Anti Human CA 19-9 Pab
165470 100 µg Ask for price

Anti Human CA 72-4 Pab
165471 100 µg Ask for price

Anti Human PAK1 Mab
831081 100 µg Ask for price

Anti Human CDK2 Mab
831085 100 µg Ask for price

Anti Human LDH1 Pab
165614 100 µg Ask for price

Anti Human Muc2 Pab
165669 100 µg Ask for price

Anti Human Muc4 Pab
165670 100 µg Ask for price

Anti Human NGFR Pab
165682 100 µg Ask for price

Anti Human PAX5 Pab
165709 100 µg Ask for price

Anti Human PAX8 Pab
165710 100 µg Ask for price

Anti Human PTEN Pab
165729 100 µg Ask for price

Anti Human TLR2 Pab
165782 100 µg Ask for price

Anti Human TLR9 Pab
165783 100 µg Ask for price

Anti Human GCSF Mab
181038 100 µg Ask for price

Anti Human GRK5 Mab
272242 100 µg Ask for price

Anti Human KLK8 Pab
272446 100 µg Ask for price

Anti Human KLK8 Mab
272447 100 µg Ask for price

Anti Human CD47 Mab
161740 100 µg Ask for price

Anti Human Flk1 Pab
162168 100 µg Ask for price

Anti Human MMP7 Pab
162385 100 µg Ask for price

Anti Human FSHR Pab
164038 100 µg Ask for price

Anti Human Muc1 Pab
164043 100 µg Ask for price

Anti Human UGRP Pab
164048 100 µg Ask for price

Anti Human TIM1 Pab
164072 100 µg Ask for price

Anti Human FABP Pab
164279 100 µg Ask for price

Anti Human GP73 Pab
164281 100 µg Ask for price

Anti Human CASR Mab
164515 100 µg Ask for price

Anti Human CD77 Pab
164516 100 µg Ask for price

Anti Human RHCT Mab
165185 100 µg Ask for price

Anti Human Tim3 Pab
165188 100 µg Ask for price

Anti Human ASIC Mab
165379 1 mg Ask for price

Anti Human ASIC Pab
165380 100 µg Ask for price

Anti Human CD6 [2G11]
165383 1 mg Ask for price

Anti Human Bcl2 Pab
165448 100 µg Ask for price

Anti Human BCMA Pab
165449 100 µg Ask for price

Anti Human BMP9 Pab
165459 100 µg Ask for price

Anti Human Braf Pab
165463 100 µg Ask for price

Anti Human CD15 Pab
165485 100 µg Ask for price

Anti Human CD38 Pab
165487 100 µg Ask for price

Anti Human CD47, Pab
165488 100 µg Ask for price

Anti Human CD54 Pab
165489 100 µg Ask for price

Anti Human CD57 Pab
165490 100 µg Ask for price

Anti Human CK20 Pab
165509 100 µg Ask for price

Anti Human CKMM Pab
165511 100 µg Ask for price

Anti Human EGFR Pab
165556 100 µg Ask for price

Anti Human CD38 Mab
100117 100 µg Ask for price

Anti Human CD22 Mab
100161 100 µg Ask for price

Anti Human GCSF Pab
111054 100 µg Ask for price

Anti Human IGF1 Pab
111091 100 µg Ask for price

Anti Human NKX2.2 Pab
111171 100 µg Ask for price

Anti Human CBX4 Pab
111235 100 µg Ask for price

Anti Human CD20 Pab
111237 100 µg Ask for price

Anti Human CD34 Pab
111290 100 µg Ask for price

Anti Human CD44 Pab
111292 100 µg Ask for price

Anti Human CD45 Pab
111293 100 µg Ask for price

Anti Human GFAP Pab
111298 100 µg Ask for price

Anti Human Toso Mab
111313 100 µg Ask for price

Anti Human PICP Pab
111508 100 µg Ask for price

Anti Human PINP Pab
111509 100 µg Ask for price

Anti Human IL35 Pab
111516 100 µg Ask for price

Anti Human GDF9 Pab
111520 100 µg Ask for price

Anti Human CD90 Mab
111529 1 mg Ask for price

Anti Human Cul1 Pab
111534 100 µg Ask for price

Anti Human Cul3 Pab
111535 100 µg Ask for price

Anti Human GLP1 Pab
111544 100 µg Ask for price

Anti Human TFPI Mab
111563 100 µg Ask for price

Anti Human SUMO Mab
111588 100 µg Ask for price

Anti Human TFPI Pab
111636 100 µg Ask for price

Anti Human CDH1 Pab
111663 100 µg Ask for price

Anti Human IL1B Pab
111683 100 µg Ask for price

Anti Human LMNA Pab
111687 100 µg Ask for price

Anti Human MCL1 Pab
111692 100 µg Ask for price

Anti Human PCNA Pab
111702 100 µg Ask for price

Anti Human PTK2 Pab
111710 100 µg Ask for price

Anti Human RELA Pab
111713 100 µg Ask for price

Anti Human RXRA Pab
111714 100 µg Ask for price

Anti Human SOX2 Pab
111715 100 µg Ask for price

Anti Human TP53 Pab
111720 100 µg Ask for price

Anti Human CSF1 Pab
111783 100 µg Ask for price

Anti Human TLR4 Pab
111784 100 µg Ask for price

Anti Human GHRP Pab
112002 100 µg Ask for price

Cohen’s d was additionally calculated to decide the impact dimension of the intervention. Statistically important adjustments have been discovered for: (i) weight, proper and left forearm circumference and hip; (ii) 6 min strolling, proper and left handgrip, sit-to-stand and sit-and-reach; (iii) the EORTC-QLQ C30 abstract rating in addition to the subscales of emotional and social functioning and signs. In all instances the route of change was constructive, whereas Cohen’s d calculated confirmed that the impact of the intervention for these parameters ranged from intermediate to giant.